{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:55:57Z","timestamp":1761897357909,"version":"3.37.3"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T00:00:00Z","timestamp":1595376000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007150","name":"United Therapeutics Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0236115","type":"journal-article","created":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T17:26:04Z","timestamp":1595438764000},"page":"e0236115","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Anti-GD2 induced allodynia in rats can be reduced by pretreatment with DFMO"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5017-9585","authenticated-orcid":true,"given":"Mitchell B.","family":"Diccianni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Kempi\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon A.","family":"Gangoti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice L.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda S.","family":"Sorkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,7,22]]},"reference":[{"issue":"6","key":"pone.0236115.ref001","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s11064-012-0764-7","article-title":"Essential roles of gangliosides in the formation and maintenance of membrane microdomains in brain tissues","volume":"37","author":"Y Ohmi","year":"2012","journal-title":"Neurochemical research"},{"issue":"12","key":"pone.0236115.ref002","first-page":"5914","article-title":"Detection of ganglioside GD2 in tumor tissues and sera of neuroblastoma patients","volume":"44","author":"G Schulz","year":"1984","journal-title":"Cancer research"},{"issue":"6","key":"pone.0236115.ref003","first-page":"2642","article-title":"Monoclonal antibodies to a glycolipid antigen on human neuroblastoma cells","volume":"45","author":"NK Cheung","year":"1985","journal-title":"Cancer research"},{"issue":"14","key":"pone.0236115.ref004","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa0911123","article-title":"Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma","volume":"363","author":"AL Yu","year":"2010","journal-title":"The New England journal of medicine"},{"issue":"7","key":"pone.0236115.ref005","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S1470-2045(17)30355-8","article-title":"Irinotecan-temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial","volume":"18","author":"R Mody","year":"2017","journal-title":"The Lancet Oncology"},{"key":"pone.0236115.ref006","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2407-11-21","article-title":"Long term outcome of high-risk neuroblastoma patients after immunotherapy with antibody ch14.18 or oral metronomic chemotherapy","volume":"11","author":"T Simon","year":"2011","journal-title":"BMC cancer"},{"key":"pone.0236115.ref007","article-title":"Update of Outcome for High-Risk Neuroblastoma Treated on a Randomized Trial of chimeric anti-GD2 antibody (ch14.18) + GM-CSF \/ IL2 immunotherapy in 1st response: A Children's Oncology Group Study","author":"A Yu","year":"2014","journal-title":"Advances in Neuroblastoma Research"},{"issue":"1355","key":"pone.0236115.ref008","article-title":"A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children\u2019s Oncology Group Study ANBL0931","volume":"9","author":"MF Ozkaynak","year":"2018","journal-title":"Frontiers in immunology"},{"issue":"3","key":"pone.0236115.ref009","first-page":"226","article-title":"Translational development of difluoromethylornithine (DFMO) for the treatment of neuroblastoma","volume":"4","author":"H Bassiri","year":"2015","journal-title":"Translational pediatrics"},{"key":"pone.0236115.ref010","article-title":"Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and Progression","author":"NF Evageliou","year":"2016","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"issue":"4","key":"pone.0236115.ref011","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00726-004-0092-6","article-title":"Inhibitors of polyamine metabolism: review article","volume":"26","author":"HM Wallace","year":"2004","journal-title":"Amino acids"},{"issue":"2","key":"pone.0236115.ref012","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1158\/1055-9965.EPI-07-0658","article-title":"The effect of difluoromethylornithine on decreasing prostate size and polyamines in men: results of a year-long phase IIb randomized placebo-controlled chemoprevention trial","volume":"17","author":"AR Simoneau","year":"2008","journal-title":"Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology"},{"issue":"1","key":"pone.0236115.ref013","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1158\/1940-6207.CAPR-08-0042","article-title":"Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial","volume":"1","author":"FL Meyskens","year":"2008","journal-title":"Cancer prevention research (Philadelphia, Pa)"},{"issue":"3","key":"pone.0236115.ref014","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/bjc.2013.15","article-title":"Role of dietary polyamines in a phase III clinical trial of difluoromethylornithine (DFMO) and sulindac for prevention of sporadic colorectal adenomas","volume":"108","author":"KP Raj","year":"2013","journal-title":"British journal of cancer"},{"issue":"5","key":"pone.0236115.ref015","doi-asserted-by":"crossref","first-page":"e0127246","DOI":"10.1371\/journal.pone.0127246","article-title":"A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed\/Refractory Neuroblastoma","volume":"10","author":"GL Saulnier Sholler","year":"2015","journal-title":"PloS one"},{"issue":"3","key":"pone.0236115.ref016","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bcp.2011.04.015","article-title":"Role of peripheral polyamines in the development of inflammatory pain","volume":"82","author":"MA Silva","year":"2011","journal-title":"Biochemical pharmacology"},{"issue":"1","key":"pone.0236115.ref017","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pain.2007.08.021","article-title":"Polyamine deficient diet to relieve pain hypersensitivity","volume":"137","author":"C Rivat","year":"2008","journal-title":"Pain"},{"issue":"10","key":"pone.0236115.ref018","doi-asserted-by":"crossref","first-page":"e77828","DOI":"10.1371\/journal.pone.0077828","article-title":"A polyamine-deficient diet prevents oxaliplatin-induced acute cold and mechanical hypersensitivity in rats","volume":"8","author":"J Ferrier","year":"2013","journal-title":"PloS one"},{"issue":"5","key":"pone.0236115.ref019","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.biopha.2009.09.022","article-title":"Polyamine reduced diet (PRD) nutrition therapy in hormone refractory prostate cancer patients","volume":"64","author":"BG Cipolla","year":"2010","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"issue":"1","key":"pone.0236115.ref020","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"SR Chaplan","year":"1994","journal-title":"Journal of neuroscience methods"},{"issue":"1","key":"pone.0236115.ref021","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF01788957","article-title":"Pharmacokinetics of anti-ganglioside GD2 mAb 14G2a in a phase I trial in pediatric cancer patients","volume":"41","author":"MM Uttenreuther-Fischer","year":"1995","journal-title":"Cancer immunology, immunotherapy: CII"},{"issue":"1","key":"pone.0236115.ref022","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/bmc.898","article-title":"Analysis of polyamines as carbamoyl derivatives in urine and serum by liquid chromatography-tandem mass spectrometry","volume":"22","author":"JA Byun","year":"2008","journal-title":"Biomedical chromatography: BMC"},{"key":"pone.0236115.ref023","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.chroma.2013.12.061","article-title":"Polyamines in biological samples: rapid and robust quantification by solid-phase extraction online-coupled to liquid chromatography-tandem mass spectrometry","volume":"1331","author":"C Magnes","year":"2014","journal-title":"Journal of chromatography A"},{"issue":"4","key":"pone.0236115.ref024","doi-asserted-by":"crossref","first-page":"c319","DOI":"10.1159\/000322830","article-title":"Sample size calculations","volume":"118","author":"M Noordzij","year":"2011","journal-title":"Nephron Clinical practice"},{"issue":"1\u20132","key":"pone.0236115.ref025","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0304-3959(96)03247-2","article-title":"An animal model of pain produced by systemic administration of an immunotherapeutic anti-ganglioside antibody","volume":"69","author":"R Slart","year":"1997","journal-title":"Pain"},{"issue":"4","key":"pone.0236115.ref026","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1213\/00000539-199710000-00014","article-title":"Intravenous lidocaine: effects on controlling pain after anti-GD2 antibody therapy in children with neuroblastoma\u2014a report of a series","volume":"85","author":"MS Wallace","year":"1997","journal-title":"Anesthesia and analgesia"},{"issue":"9","key":"pone.0236115.ref027","doi-asserted-by":"crossref","first-page":"e25220","DOI":"10.1371\/journal.pone.0025220","article-title":"A monoclonal antibody to O-acetyl-GD2 ganglioside and not to GD2 shows potent anti-tumor activity without peripheral nervous system cross-reactivity","volume":"6","author":"N Alvarez-Rueda","year":"2011","journal-title":"PloS one"},{"issue":"1","key":"pone.0236115.ref028","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1213\/00000539-199801000-00022","article-title":"Gabapentin reverses the allodynia produced by the administration of anti-GD2 ganglioside, an immunotherapeutic drug","volume":"86","author":"S Gillin","year":"1998","journal-title":"Anesthesia and analgesia"},{"issue":"1\u20132","key":"pone.0236115.ref029","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0304-3959(96)03280-0","article-title":"Electrophysiological characteristics of primary afferent fibers after systemic administration of anti-GD2 ganglioside antibody","volume":"69","author":"WH Xiao","year":"1997","journal-title":"Pain"},{"issue":"1","key":"pone.0236115.ref030","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.pain.2010.01.024","article-title":"Anti-GD(2) with an FC point mutation reduces complement fixation and decreases antibody-induced allodynia","volume":"149","author":"LS Sorkin","year":"2010","journal-title":"Pain"},{"issue":"4","key":"pone.0236115.ref031","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/0306-4522(94)90560-6","article-title":"N-methyl-D-aspartate receptor-mediated changes in thermal nociception: allosteric modulation at glycine and polyamine recognition sites","volume":"63","author":"R Kolhekar","year":"1994","journal-title":"Neuroscience"},{"issue":"2","key":"pone.0236115.ref032","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0014-4886(87)90141-5","article-title":"Changes of ornithine decarboxylase activity in dorsal root ganglion cells after axon injury: possible relationship to alterations in neuronal chromatin","volume":"95","author":"MR Wells","year":"1987","journal-title":"Experimental neurology"},{"issue":"4","key":"pone.0236115.ref033","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.pbb.2011.07.002","article-title":"Contribution of peripheral vanilloid receptor to the nociception induced by injection of spermine in mice","volume":"99","author":"C Gewehr","year":"2011","journal-title":"Pharmacology, biochemistry, and behavior"},{"issue":"1\u20132","key":"pone.0236115.ref034","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0006-8993(01)03408-4","article-title":"Antibody directed against GD(2) produces mechanical allodynia, but not thermal hyperalgesia when administered systemically or intrathecally despite its dependence on capsaicin sensitive afferents","volume":"930","author":"LS Sorkin","year":"2002","journal-title":"Brain research"},{"issue":"6","key":"pone.0236115.ref035","first-page":"1145","article-title":"The Association Between Musculoskeletal Pain and Circulating Ornithine: A Population-Based Study","volume":"18","author":"P Mantyselka","year":"2017","journal-title":"Pain medicine (Malden, Mass)"},{"key":"pone.0236115.ref036","doi-asserted-by":"crossref","first-page":"742407","DOI":"10.1155\/2013\/742407","article-title":"Plasma amino acids changes in complex regional pain syndrome","volume":"2013","author":"GM Alexander","year":"2013","journal-title":"Pain research and treatment"},{"issue":"6","key":"pone.0236115.ref037","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1034\/j.1600-0773.2001.880609.x","article-title":"Polyamine and redox modulation of [3H]MK-801 binding to N-methyl-D-aspartate receptors in the spinal cord and cerebral cortex","volume":"88","author":"E Sundstr\u00f6m","year":"2001","journal-title":"Pharmacology & toxicology"},{"issue":"1","key":"pone.0236115.ref038","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.brainres.2004.02.027","article-title":"Nociceptive behavior induced by poly-L-lysine and other basic compounds involves the spinal NMDA receptors","volume":"1008","author":"K Tan-No","year":"2004","journal-title":"Brain research"},{"issue":"2","key":"pone.0236115.ref039","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/neu.10308","article-title":"Novel changes in gene expression following axotomy of a sympathetic ganglion: a microarray analysis","volume":"59","author":"KL Boeshore","year":"2004","journal-title":"Journal of neurobiology"},{"issue":"9","key":"pone.0236115.ref040","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/WNR.0000000000001031","article-title":"Evaluation of apoptotic pathways in dorsal root ganglion neurons following peripheral nerve injury","volume":"29","author":"R Wiberg","year":"2018","journal-title":"Neuroreport"},{"key":"pone.0236115.ref041","doi-asserted-by":"crossref","first-page":"e331","DOI":"10.1038\/cddis.2012.71","article-title":"Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress","volume":"3","author":"M Mecha","year":"2012","journal-title":"Cell death & disease"},{"issue":"1\u20133","key":"pone.0236115.ref042","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejphar.2008.11.060","article-title":"A single subcutaneous injection of ozone prevents allodynia and decreases the over-expression of pro-inflammatory caspases in the orbito-frontal cortex of neuropathic mice","volume":"603","author":"C Fuccio","year":"2009","journal-title":"European journal of pharmacology"},{"issue":"4","key":"pone.0236115.ref043","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1159\/000443096","article-title":"Endoplasmic Reticulum Stress is Involved in DFMO Attenuating Isoproterenol-Induced Cardiac Hypertrophy in Rats","volume":"38","author":"Y Lin","year":"2016","journal-title":"Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology"},{"issue":"1","key":"pone.0236115.ref044","doi-asserted-by":"crossref","first-page":"14445","DOI":"10.1038\/s41598-018-32659-w","article-title":"Maintenance DFMO Increases Survival in High Risk Neuroblastoma","volume":"8","author":"GLS Sholler","year":"2018","journal-title":"Scientific reports"},{"issue":"3","key":"pone.0236115.ref045","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1517\/14728222.2014.986459","article-title":"Disialoganglioside GD2 as a therapeutic target for human diseases","volume":"19","author":"M Suzuki","year":"2015","journal-title":"Expert opinion on therapeutic targets"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0236115","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:41:40Z","timestamp":1667522500000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0236115"}},"subtitle":[],"editor":[{"given":"Giuseppe","family":"Biagini","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,7,22]]},"references-count":45,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0236115","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2020,7,22]]}}}